1Kamatak T, Yokoi T. Yamayoshi Y, et al. Strategic Proposals to avoid toxic drug intereactions during new drug development: molecular toxicology proposals. J Toxicol Sci,1996,21:305.
2Anastasio GD,Cornell K, Menscer D.Drug interaction:keeping it straight. Am Fam Physician, 1997,56:883,891.
3Honig PK,Woosley RL, lamanik ,et al.Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant of erythromycin. Clin Pharmacol Ther, 1992,52:231.
5Ajayi FO, Sun H, Perry J. Adverse drug reactions: a review of relevant factors.J Clin Pharmacol,2000,40:1039.
6Laggarou J, Pomeranz BH, Cerey PN. Incidnce of adverse drug reactions in hospitalized patients. a meta-analysis of prospective studies. JAMA, 1998,279:1205.
